Population-based study of the epidemiology and the risk factors for pseudomonas aeruginosa bloodstream infection

Infection

Volumn 38, Issue 1, 2010, Pages 25-32

  Parkins, M D ^a,b,d   Gregson, D B ^a,b   Pitout, J D D ^b,c   Ross, T ^c   Laupland, K B ^a,b,c  

^a Calgary Health Region   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c CALGARY LABORATORY SERVICES   (Canada)

^d FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BACTEREMIA; BLOODSTREAM INFECTION; CANADA; CHRONIC LIVER DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; EPIDEMIC; FEMALE; HEART DISEASE; HIGH RISK POPULATION; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; NONHUMAN; OUTCOME ASSESSMENT; POPULATION RESEARCH; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; RISK FACTOR; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; CANADA; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 77549085647     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-009-9145-9     Document Type: Article

References (48)

1. S. Unal R. Masterton H. Goossens 2004 Bacteraemia in Europe-antimicrobial susceptibility data from the MYSTIC surveillance programme Int J Antimicrob Agents 23 155 163 10.1016/j.ijantimicag.2003.07.003 1:CAS:528: DC%2BD2cXpsVOmtg%3D%3D 15013041 (Pubitemid 38175397)
2. J. Mallolas J.M. Gatell J.M. Miro F. Marco J. Bisbe A. M. de Jimenez 1991 Analysis of prognostic factors in 274 consecutive episodes of Pseudomonas aeruginosa bacteremia Antibiot Chemother 44 106 114 1:STN:280: DyaK387psl2ltg%3D%3D 1801628
3. H. Wisplinghoff H. Seifert M. Coimbra R.P. Wenzel M.B. Edmond 2001 Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infection due to Staphylococcus aureus Clin Infect Dis 33 733 736 10.1086/322610 1:STN:280:DC%2BD3Mvktleltg%3D%3D 11486296 (Pubitemid 32762951)
4. M. Hilf V.L. Yu J. Sharp J.J. Zuravleff J.A. Korvick R.R. Muder 1989 Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients Am J Med 87 540 546 1:STN:280: DyaK3c%2FltlKgtg%3D%3D 2816969
5. J. Mallolas J.M. Gatell J.M. Miro M. Almela E. Soriano 1991 Prognostic factors for Pseudomonas aeruginosa bacteremia Am J Med 90 134 10.1016/0002-9343(91)90521-X 1:STN:280:DyaK3M%2Fps1yiuw%3D%3D 1986584
6. F. Vidal J. Mensa M. Almela J.A. Martinez F. Marco C. Casals 1996 Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment: analysis of 189 episodes Arch Intern Med 156 2121 2126 10.1001/archinte.156.18.2121 1:STN:280: DyaK2s%2FhsFChtg%3D%3D 8862105 (Pubitemid 26346971)
7. Y. Siegman-Igra R. Ravona H. Primerman M. Giladi 1998 Pseudomonas aeruginosa bacteremia: an analysis of 123 episodes, with particular emphasis on the effect of antibiotic therapy Int J Infect Dis 2 211 215 10.1016/S1201- 9712(98)90055-8 1:STN:280:DyaK1cvjslCktA%3D%3D 9763504 (Pubitemid 28422099)
8. I. Chatzinikolaou D. Abi-Said G.P. Bodey K.V. Rolston J.J. Tarrand G. Samonis 2000 Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: retrospective analysis of 245 episodes Arch Intern Med 160 501 509 10.1001/archinte.160.4.501 1:CAS:528:DC%2BD3cXhvFGhur0%3D 10695690
9. G.P. Bodey L. Jadeja L. Elting 1985 Pseudomonas bacteremia: retrospective analysis of 410 episodes Arch Intern Med 145 1621 1629 10.1001/archinte.145.9. 1621 1:STN:280:DyaL2M3nvVGnug%3D%3D 3927867 (Pubitemid 16258204)
10. S.T. Micek A.E. Lloyd D.J. Ritchie R.M. Reichley V.J. Fraser M.H. Kollef 2005 Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment Antimicrob Agents Chemother 49 1306 1311 10.1128/AAC.49.4.1306-1311.2005 1:CAS:528:DC%2BD2MXjt1Gjsr4%3D 15793102 (Pubitemid 40463352)
11. C.I. Kang S.H. Kim H.B. Kim S.W. Park Y.J. Choe M.D. Oh 2003 Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome Clin Infect Dis 37 745 751 10.1086/377200 12955633 (Pubitemid 37153651)
12. S. Osmon S. Ward V.J. Fraser M.H. Kollef 2004 Hospital mortality for patients with bacteremia due to Staphylococcus aureus or Pseudomonas aeruginosa Chest 125 607 616 10.1378/chest.125.2.607 14769745 (Pubitemid 38223643)
13. P.G. Gallagher C. Watanakunakorn 1989 Pseudomonas bacteremia in a community teaching hospital, 1980-1984 Rev Infect Dis 11 846 852 1:STN:280:DyaK3c7gtValsg%3D%3D 2602775
14. S.C. Chen R.H. Lawrence K. Byth T.C. Sorrell 1993 Pseudomonas aeruginosa bacteraemia: is pancreatobiliary disease a risk factor Med J Aust 159 592 597 1:STN:280:DyaK2c%2FkvFektw%3D%3D 8232033
15. C.I. Kang S.H. Kim W.B. Park K.D. Lee H.B. Kim E.C. Kim 2005 Clinical features and outcome of patients with community-acquired Pseudomonas aeruginosa bacteraemia Clin Microbiol Infect 11 415 418 10.1111/j.1469-0691.2005.01102.x 15819873 (Pubitemid 40575830)
16. G. Grisaru-Soen L. Lerner-Geva N. Keller H. Berger J.H. Passwell A. Barzilai 2000 Pseudomonas aeruginosa bacteremia in children: analysis of trends in prevalence, antibiotic resistance and prognostic factors Pediatr Infect Dis J 19 959 963 10.1097/00006454-200010000-00003 1:STN:280:DC%2BD3M3gt1Cntg%3D%3D 11055596 (Pubitemid 30804678)
17. S. Blot K. Vandewoude E. Hoste F. Colardyn 2003 Reappraisal of attributable mortality in critically ill patients with nosocomial bacteraemia involving Pseudomonas aeruginosa J Hosp Infect 53 18 24 10.1053/jhin.2002.1329 1:STN:280:DC%2BD38jjtl2mug%3D%3D 12495681 (Pubitemid 38002084)
18. A.R. Marra G.M. Bearman R.P. Wenzel M.B. Edmond 2006 Comparison of severity of illness scoring systems for patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa BMC Infect Dis 6 132 10.1186/1471-2334-6-132 16916466 (Pubitemid 44377000)
19. J.A. Korvick J.W. Marsh T.E. Starzl V.L. Yu 1991 Pseudomonas aeruginosa bacteremia in patients undergoing liver transplantation: an emerging problem Surgery 109 62 68 1:STN:280:DyaK3M%2FotF2htA%3D%3D 1984637
20. J. Koprnova P. Beno J. Korcova M. Mrazova E. Grey A. Liskova 2005 Bacteremia due to Pseudomonas aeruginosa: results from a 3-year national study in the Slovak Republic J Chemother 17 470 476 1:STN:280:DC%2BD2Mnkt1ekug%3D%3D 16323434
21. L. Aliaga J.D. Mediavilla F. Cobo 2002 A clinical index predicting mortality with Pseudomonas aeruginosa bacteraemia J Med Microbiol 51 615 619 12132781
22. M.N. Al-Hasan J.W. Wilson B.D. Lahr J.E. Eckel-Passow L.M. Baddour 2008 Incidence of Pseudomonas aeruginosa bacteremia: a population-based study Am J Med 121 702 708 10.1016/j.amjmed.2008.03.029 18691484
23. K.B. Laupland D.L. Church M. Mucenski L.R. Sutherland H.D. Davies 2003 Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections J Infect Dis 187 1452 1459 10.1086/374621 12717627 (Pubitemid 36549691)
24. K.B. Laupland T. Ross J.D. Pitout D.L. Church D.B. Gregson 2007 Investigation of sources of potential bias in laboratory surveillance for anti-microbial resistance Clin Invest Med 30 E159 E166 17716594
25. V.N. Okamoto G.D. Rubenfeld 2004 Attending to the lightness of numbers: toward the understanding of critical care epidemiology Crit Care 8 422 424 10.1186/cc2952 15566607 (Pubitemid 40073671)
26. B.G. Iversen A.B. Brantsaeter P. Aavitsland 2008 Nationwide study of invasive Pseudomonas aeruginosa infection in Norway: importance of underlying disease J Infect 57 139 146 10.1016/j.jinf.2008.05.010 18617269
27. Medical Officer of Health, Calgary Health Region. Health of the Region, 2006. Available at: http://www.calgaryhealthregion.ca/communications/ regionhealth/index.htm. Accessed 26 April 2007.
28. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. Approved standard M7-A6 ed. National Committee for Clinical Laboratory Standards, Wayne 2003.
29. K.B. Laupland M.D. Parkins D.L. Church D.B. Gregson T.J. Louie J.M. Conly 2005 Population-based epidemiological study of infections caused by carbapenem-resistant Pseudomonas aeruginosa in the Calgary Health Region: importance of metallobeta-lactamase (MBL)-producing strains J Infect Dis 192 1606 1612 10.1086/444469 16206075 (Pubitemid 41504696)
30. J.D. Pitout D.B. Gregson L. Poirel J.A. McClure P. Le D.L. Church 2005 Detection of Pseudomonas aeruginosa producing metallo-betalactamases in a large centralized laboratory J Clin Microbiol 43 3129 3135 10.1128/JCM.43.7.3129-3135. 2005 1:CAS:528:DC%2BD2MXntlSmtb8%3D 16000424 (Pubitemid 40981312)
31. N.D. Friedman K.S. Kaye J.E. Stout S.A. McGarry S.L. Trivette J.P. Briggs 2002 Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections Ann Intern Med 137 791 797 12435215
32. Population by Alberta Regional Health Authorities. Health Systems Analysis Unit, Calgary Health Region. Available at: http://www. calgaryhealthregion.ca/qshi/hsau/Demographic-Data/DemographicData.html. Accessed 4 Feb 2008.
33. Southern Alberta Clinic. Epidemiology of HIV. Available at: http://www.calgaryhealthregion.ca/clin/sac/epidemio.htm. Accessed 15 Nov 2007.
34. ALTRA Southern Alberta Transplant Program. Available at: http://www.calgaryhealthregion.ca/altra/index.htm. Accessed 15 Nov 2007.
35. B.J. Manns G.P. Mortis K.J. Taub K. McLaughlin C. Donaldson W.A. Ghali 2001 The Southern Alberta Renal Program database: a prototype for patient management and research initiatives Clin Invest Med 24 164 170 1:STN:280:DC%2BD3MrhtFCjsA%3D%3D 11558850
36. Health Canada. Statistical report on the health of Canadians. Available at: http://www.statcan.ca/english/freepub/82-570-XIE/intro.htm. Accessed 25 April 2007.
37. C.N. Bernstein A. Wajda L.W. Svenson A. MacKenzie M. Koehoorn M. Jackson 2006 The epidemiology of inflammatory bowel disease in Canada: a population-based study Am J Gastroenterol 101 1559 1568 10.1111/j.1572-0241. 2006.00603.x 16863561 (Pubitemid 43980630)
38. S.E. Gabriel C.S. Crowson W.M. O'Fallon 1999 The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985 Arthritis Rheum 42 415 420 10.1002/1529-0131(199904)42:3<415::AID-ANR4>3.0.CO;2-Z 1:STN:280:DyaK1M7os1KhsQ%3D%3D 10088762 (Pubitemid 29136087)
39. M.C. Hochberg D.L. Perlmutter T.A. Medsger V. Steen M.H. Weisman B. White 1995 Prevalence of self-reported physician-diagnosed systemic lupus erythematosus in the USA Lupus 4 454 456 10.1177/096120339500400606 1:STN:280:DyaK28zltlajtQ%3D%3D 8749567
40. J. Bisbe J.M. Gatell J. Puig J. Mallolas J.A. Martinez A. M. de Jimenez 1988 Pseudomonas aeruginosa bacteremia: univariate and multivariate analyses of factors influencing the prognosis in 133 episodes Rev Infect Dis 10 629 635 1:STN:280:DyaL1c3nslKjsw%3D%3D 3393785
41. H.D. Davies A. McGeer B. Schwartz K. Green D. Cann A.E. Simor 1996 Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group N Engl J Med 335 547 554 10.1056/NEJM199608223350803 1:STN:280:DyaK28zhtVOlsw%3D%3D 8684408 (Pubitemid 26272309)
42. M.M. Farley R.C. Harvey T. Stull J.D. Smith A. Schuchat J.D. Wenger 1993 A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults N Engl J Med 328 1807 1811 10.1056/NEJM199306243282503 1:STN:280:DyaK3s3nsFektA%3D%3D 8502269 (Pubitemid 23174711)
43. D.M. Livermore R. Hope G. Brick M. Lillie R. Reynolds 2008 Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001-2006 J Antimicrob Chemother 62 [Suppl2] ii55 ii63 10.1093/jac/dkn352 1:CAS:528:DC%2BD1cXht1eksb%2FI 18819980
44. R. Reynolds N. Potz M. Colman A. Williams D. Livermore A. MacGowan 2004 Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme J Antimicrob Chemother 53 1018 1032 10.1093/jac/dkh232 1:CAS:528: DC%2BD2cXksVaitbc%3D 15128723 (Pubitemid 38807644)
45. V.H. Tam E.A. Gamez J.S. Weston L.N. Gerard M.T. Larocco J.P. Caeiro 2008 Outcomes of bacteremia due to Pseudomonas aeruginosa with reduced susceptibility to piperacillin-tazobactam: implications on the appropriateness of the resistance breakpoint Clin Infect Dis 46 862 867 10.1086/528712 18279040
46. M.H. Scheetz M.K. Bolon K.K. Scarsi M.A. Fotis M.J. Postelnick 2006 Lack of effect of fluoroquinolone resistance on mortality in subjects with Pseudomonas aeruginosa bacteraemia J Infect 52 105 110 10.1016/j.jinf.2005.03. 007 15904961 (Pubitemid 43137392)
47. A.R. Marra C.A. Pereira A.C. Gales L.C. Menezes R.G. Cal J.M. de Souza 2006 Bloodstream infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: epidemiology, microbiology, and clinical outcomes Antimicrob Agents Chemother 50 388 390 10.1128/AAC.50.1.388-390.2006 1:CAS:528: DC%2BD28XivVKisg%3D%3D 16377720 (Pubitemid 43042955)
48. J.P. Phair H.P. Bassaris J.E. Williams E. Metzger 1983 Bacteremic pneumonia due to gram-negative bacilli Arch Intern Med 143 2147 2149 10.1001/archinte.143.11.2147 1:STN:280:DyaL2c%2FltFGksQ%3D%3D 6639235 (Pubitemid 14225186)